NCP Inc. Purchases 2,245 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

NCP Inc. increased its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 67.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,555 shares of the real estate investment trust’s stock after acquiring an additional 2,245 shares during the quarter. NCP Inc.’s holdings in Omega Healthcare Investors were worth $226,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Assetmark Inc. raised its position in shares of Omega Healthcare Investors by 1.7% in the 3rd quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock valued at $48,492,000 after purchasing an additional 19,542 shares during the last quarter. Caxton Associates LP purchased a new stake in Omega Healthcare Investors during the 2nd quarter valued at about $1,652,000. Daiwa Securities Group Inc. increased its holdings in shares of Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after purchasing an additional 3,003,845 shares during the period. Van ECK Associates Corp increased its holdings in shares of Omega Healthcare Investors by 15.4% in the third quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust’s stock valued at $4,167,000 after purchasing an additional 13,367 shares during the period. Finally, Cetera Advisors LLC purchased a new position in shares of Omega Healthcare Investors in the first quarter worth about $646,000. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Performance

OHI opened at $40.77 on Wednesday. The company has a market cap of $11.01 billion, a price-to-earnings ratio of 29.98, a PEG ratio of 1.25 and a beta of 0.99. The firm’s fifty day simple moving average is $40.61 and its two-hundred day simple moving average is $37.19. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42.

Omega Healthcare Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.57%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s payout ratio is 197.06%.

Insiders Place Their Bets

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on OHI shares. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research report on Thursday, October 31st. BMO Capital Markets increased their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 target price for the company. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Finally, Royal Bank of Canada boosted their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $40.00.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.